Experimental pill sends one THIRD of leukemia patients in early trial to complete remission
An experimental pill for leukemia has shown promise in early clinical trials and has brought one-third of patients with aggressive disease into complete remission.The drug - revumenib - was also credited with putting half of patients with…
Read More...
Read More...